glp-1 and thyroid medication GLP-1RA cancer: New study suggests detection bias, not causation list of glp 1 medications

Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.

Glucagon-like peptide 1 (GLP-1) based therapies have seen a meteoric rise in popularity (about 300%1 increased use between 2018-2023)

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

Learn How GLP-1 And Ozempic Differ For Weight Loss At Frisco Quick Care

In this weeks edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more.